Latest Research & Reports

November brings attention to the impact T1D has on millions of lives. This month, we focus on the growing burden of T1D, and why we need a cure.

Only the board holds the power to influence change and expedite progress toward a Practical Cure.

Annual review of compensation at two of the largest diabetes nonprofits in the US: Breakthrough T1D and the American Diabetes Association.

A clinical trial in China is being hailed as a ‘cure’ after releasing 1-year follow-up results. Here is what you need to know.

The ‘COVALENT-112’ phase II human trial, placed on clinical hold last June, is cleared by the FDA to continue.

Nonprofits promise proceeds fund cure research, but less than 15% actually goes toward a cure.